B of A Securities analyst Travis Steed maintains Becton Dickinson (NYSE:BDX) with a Neutral and r

On a recent edition of CNBC's Mad Money Lightning Round, Jim Cramer fielded questions from viewers.

STANCE trial surpasses a key enrollment milestone, advancing the clinical evaluation of GalaFLEX LIT

FRANKLIN LAKES, N.J., Aug. 26, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),

On August 26, 2026, we conducted a DCF analysis for Becton Dickinson and Co (BDX), a company that ha

BD concludes PREVENT trial enrollment, advancing Phasix Mesh toward a potential FDA submission for i

FDA alerts Becton Dickinson customers to remove recalled Huons sodium chloride ampules from convenie

FRANKLIN LAKES, N.J., Aug. 17, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),

Four Dividend Kings - Becton, Dickinson and Company (BDX), Consolidated Edison (ED), Emerson Electri

Becton Dickinson gets its prior buy rating reaffirmed again, agreeing with the latest Wall St consen

FDA alerts providers as Medline corrects convenience kits with recalled BD applicators due to steril

RBC Capital analyst Kendall Au maintains Becton Dickinson (NYSE:BDX) with a Sector Perform and ra

On August 12, 2026, we delve into the DCF analysis for Becton Dickinson and Co (BDX), a company that

Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisiona

Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisiona

On June 30, 2026, First Eagle Investment (Trades, Portfolio) executed a significant add transaction

About a year ago, 24/7 Wall St. flagged four overlooked Dividend Aristocrats as stealth growth plays

Revenue: $5 billion, up 4.4% on an FX-neutral basis.Adjusted Operating Margin: 24.9%, down 130 basis

Becton, Dickinson and Company NYSE: BDX reported third-quarter fiscal 2026 revenue of $5 billion, up

Citigroup analyst Joanna Wiensch maintains Becton Dickinson (NYSE:BDX) with a Buy and raises the

RBC Capital analyst Kendall Au maintains Becton Dickinson (NYSE:BDX) with a Sector Perform and ra

Piper Sandler analyst Jason Bednar maintains Becton Dickinson (NYSE:BDX) with a Neutral and raise

Wells Fargo analyst Lawrence Biegelsen maintains Becton Dickinson (NYSE:BDX) with a Equal-Weight

BDX tops third-quarter fiscal 2026 earnings and revenue estimates as broad segment growth offset pre

Becton, Dickinson and Company (BDX) Q3 2026 Earnings Call Transcript

Becton, Dickinson and Co (NYSE:BDX) on Thursday reported third-quarter adjusted earnings of $3.23 pe

Becton Dickinson raises 2026 adjusted EPS guidance after reporting Q3 revenue growth across core med

The headline numbers for Becton Dickinson (BDX) give insight into how the company performed in the q

Becton Dickinson (BDX) came out with quarterly earnings of $3.23 per share, beating the Zacks Consen

Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.23 per share which beat the analyst c

Becton Dickinson (NYSE:BDX) raises FY2026 Adj EPS guidance from $12.52-$12.72 to $12.62-$12.72 vs $1

Revenue of $5.0 billion increased 5.4% as reported, 4.4% FXN GAAP and adjusted diluted EPS from cont

BDX's Medical Essentials and Interventional strength may drive third-quarter fiscal 2026 results, bu

TD Cowen analyst Joshua Jennings maintains Becton Dickinson (NYSE:BDX) with a Hold and raises the

UBS analyst Patrick Wood initiates coverage on Becton Dickinson (NYSE:BDX) with a Buy rating and

Evercore ISI Group analyst Vijay Kumar maintains Becton Dickinson (NYSE:BDX) with a Outperform an

The contract was awarded following a review by hospital experts serving on Vizient's client-led

Barclays analyst Matt Miksic maintains Becton Dickinson (NYSE:BDX) with a Overweight and raises t

Wells Fargo analyst Lawrence Biegelsen maintains Becton Dickinson (NYSE:BDX) with a Equal-Weight

Becton Dickinson (NYSE: BDX) tops Q2 estimates with $4.71B revenue and raises 2026 earnings outlook.

Becton Dickinson (NYSE:BDX) raises FY2026 Adj EPS guidance from $12.35-$12.65 to $12.52-$12.72 vs $1

Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $2.90 per share which beat the analyst c

By integrating the BD Pyxis™ Pro and BD Alaris™ platforms, Wellstar Health System is giving clinicia

TD Cowen analyst Joshua Jennings maintains Becton Dickinson (NYSE:BDX) with a Hold and lowers the

Piper Sandler analyst Jason Bednar maintains Becton Dickinson (NYSE:BDX) with a Neutral and lower

Goldman Sachs analyst David Roman reinstates Becton Dickinson (NYSE:BDX) with a Neutral and annou

CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment o

Argus Research analyst David Toung maintains Becton Dickinson (NYSE:BDX) with a Buy and lowers th

This latest addition to the Surgiphor portfolio empowers clinicians to mechanically loosen and remov